Symptomatic remission and neurocognitive functioning in patients with schizophrenia

Psychological Medicine

Volumn 41, Issue 10, 2011, Pages 2131-2139

  Hofer, A ^a   Bodner, T ^a   Kaufmann, A ^a   Kemmler, G ^a   Mattarei, U ^a   Pfaffenberger, N M ^a   Rettenbacher, M A ^a   Trebo, E ^a   Yalcin, N ^a   Fleischhacker, W W ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Neurocognition; remission; schizophrenia

Indexed keywords

ADULT; ARTICLE; COGNITION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INTELLIGENCE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REMISSION; SCHIZOPHRENIA; STATISTICAL MODEL;

ADULT; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTELLIGENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 80054962627     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711000353     Document Type: Article

References (41)

1. Andreasen NC, Carpenter Jr WT, Kane JM, Lasser RA, Marder SR, Weinberger DR (2005). Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 162, 441-449. (Pubitemid 40343909)
2. Aschenberger S, Tucher O, Lange KW (2000). Regensburger Wörtflüssigkeits-Test. Hogrefe Verlag für Psychologie : Göttingen.
3. Benton AS, Spreen O (1996). Der Benton Test. Handbuch: 7. Auflage. Huber: Bern.
4. Bond GR, Drake RE (2008). Predictors of competitive employment among patients with schizophrenia. Current Opinion in Psychiatry 21, 362-369. (Pubitemid 351787139)
5. Bryson G, Bell MD (2003). Initial and final work performance in schizophrenia: cognitive and symptom predictors. Journal of Nervous and Mental Disease 191, 87-92. (Pubitemid 36231862)
6. Buckley PF, Harvey PD, Bowie CR, Loebel A (2007). The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophrenia Research 94, 99-106. (Pubitemid 47031575)
7. Catty J, Lissouba P, White S, Becker T, Drake R, Fiorty A, Knapp M, Lauber C, Rössler W, Tomov T, van Busschbach J, Wiersma D, Burns T (2008). Predictors of employment for people with severe mental illness: results of an international six-centre randomised controlled trial. British Journal of Psychiatry 192, 224-231. (Pubitemid 351347382)
8. Cervellione KL, Burdick KE, Cottone JG, Rhinewine JP, Kumra S (2007). Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome. Journal of the American Academy of Child and Adolescent Psychiatry 46, 867-878. (Pubitemid 46975923)
9. ́ Ciudad A, Alvarez E, Bobes J, San L, Polavieja P, Gilaberte I (2009). Remission in schizophrenia: results from a 1-year follow-up observational study. Schizophrenia Research 108, 214-222
10. Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Kahn RS (2009). Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). American Journal of Psychiatry 166, 675-682.
11. Delis DC, Kramer JH, Kaplan E, Ober BA (1987). California Verbal Learning and Memory Test (Manual). Psychological Corporation: San Antonio, TX.
12. Fleischhacker WW, Hummer M, Hofer A (2008). Schizophrene Störungen. In Handbuch der Psychopharmakotherapie (ed. F. Holsboer, G. Grü nder and O. Benkert), pp. 847-872. Springer-Verlag: Heidelberg.
13. Fujii DE, Wylie AM (2003). Neurocognition and community outcome in schizophrenia: long-term predictive validity. Schizophrenia Research 59, 219-223. (Pubitemid 35284695)
14. Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF (2002). Cognitive correlates of job tenure among patients with severe mental illness. American Journal of Psychiatry 159, 1395-1402. (Pubitemid 34832723)
15. Green MF, Kern RS, Braff DL, Mintz J (2000). Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophrenia Bulletin 26, 119-136. (Pubitemid 30317696)
16. Harvey PD, Green MF, Keefe RSE, Velligan DI (2004). Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. Journal of Clinical Psychiatry 5, 361-372.
17. Heaton RK, Chelune GJ, Taley JL, Kay GG, Curtiss G (1993). Wisconsin Card Sorting Test Manual: Revised and Expanded. Psychological Assessment Resources : Odessa, FL.
18. Helldin L, Kane JM, Karilampi U, Norlander T, Archer T (2006). Remission and cognitive ability in a cohort of patients with schizophrenia. Psychiatry Research 40, 738-745. (Pubitemid 44486248)
19. Hofer A, Baumgartner S, Bodner T, Edlinger M, Hummer M, Kemmler G, Rettenbacher MA, Fleischhacker WW (2005). Patient outcomes in schizophrenia II: the impact of cognition. European Journal of Psychiatry 20, 395-402. (Pubitemid 41318005)
20. Jarboe KS, Schwartz SK (1999). The relationship between medication noncompliance and cognitive function in patients with schizophrenia. Journal of the American Nurses' Association 5, S2-S8.
21. Kaneda Y, Jayathilak H, Meltzer H (2010). Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment. Psychiatry Research 178, 57-62.
22. Kay SR, Fiszbein A, Opler LA (1987). The Positive and Negative Syndrome Scale for schizophrenia. Schizophrenia Bulletin 13, 261-276. (Pubitemid 18039085)
23. Keefe RS (2007). Cognitive deficits in patients with schizophrenia: effects and treatment. Journal of Clinical Psychiatry 68 (Suppl. 14), 8-13.
24. Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano GT, Stroup S, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA; for the CATIE Investigators and the Neurocognitive Working Group (2007). Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry 64, 633-647. (Pubitemid 46878665)
25. Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walker TM, Stroup TS, McEvoy JP, Lieberman JA (2006). Baseline neurocognitive deficits in the CATIE Schizophrenia Trial. Neuropsychopharmacology 31, 2033-2046.
26. Kern RS, Green MF, Satz P (1992). Neuropsychological predictors of skills training for chronic psychiatric patients. Psychiatry Research 43, 223-230.
27. Kopelowicz A, Liberman RP, Ventura J, Zarate R, Mintz J (2005). Neurocognitive correlates of recovery from schizophrenia. Psychological Medicine 35, 1165-1173. (Pubitemid 41103008)
28. Lehrl S (1977). Manual zum Mehrfachwahl-Wortschatz-Test-B (Multiple Choice Word Knowledge Test). Straube: Erlangen.
29. Leucht S, Komossa K, Rummel-Kluge C, Corves C, Hunger H, Schmid F, Asenjo Lobos C, Schwarz S, Davis JM (2009). A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. American Journal of Psychiatry 166, 152-163.
30. McClure MM, Bowie CR, Patterson TL, Heaton RK, Weaver C, Anderson H, Harvey PD (2007). Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia : evidence for specificity of relationships? Schizophrenia Research 89, 330-338. (Pubitemid 44881282)
31. Nelson HE (1992). National Adult Reading Test (NART). NFER-Nelson: Windsor, UK.
32. Norman R, Malla AK, Cortese L, Cheng S, Diaz K, McIntosh E, McLean TS, Rickwood A, Voruganti LP (1999). Symptoms and cognition as predictors of community functioning: a prospective analysis. American Journal of Psychiatry 156, 400-405. (Pubitemid 29124161)
33. Palmer BW, Dawes SE, Heaton RK (2009). What do we know about neuropsychological aspects of schizophrenia? Neuropsychological Review 19, 365-384.
34. Rempfer MV, Hamera EK, Brown CE, Cromwell RL (2003). The relations between cognition and the independent living skill of shopping in people with schizophrenia. Psychiatry Research 117, 103-112. (Pubitemid 36246706)
35. van Os J, Burns T, Cavallaro R, Leucht S, Peuskens J, Helldin L, Bernardo M, Arango C, Fleischhacker WW, Lachaux B, Kane JM (2006). Standardized remission criteria in schizophrenia. Acta Psychiatrica Scandinavica 113, 91-95. (Pubitemid 43348370)
36. Velligan DI, Bow-Thomas CC, Mahurin RK, Miller AL, Halgunseth LC (2000). Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? Journal of Nervous and Mental Disease 188, 518-524. (Pubitemid 30641896)
37. Velligan DI, Mahurin RK, Diamond PL, Hazleton BC, Eckert SL, Miller AL (1997). The functional significance of symptomatology and cognitive function in schizophrenia. Schizophrenia Research 25, 21-31. (Pubitemid 27239627)
38. Wegener S, Redoblado-Hodge MA, Lucas S, Fitzgerald D, Harris A, Brennan J (2005). Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Australian and New Zealand Journal of Psychiatry 39, 487-492. (Pubitemid 40940993)
39. Williams LM, Withford TJ, Flynn G, Wong W, Liddell BJ, Silverstein S, Galletly C, Harris AW, Gordon E (2008). General and social cognition in first episode schizophrenia : identification if separable factors and prediction of functional outcome using the IntegNeuro test battery. Schizophrenia Research 99, 182-191. (Pubitemid 351255579)
40. Zanello A, Perrig L, Huguelet P (2006). Cognitive functions related to interpersonal problem-solving skills in schizophrenic patients compared with healthy subjects. Psychiatry Research 142, 67-78. (Pubitemid 43775794)
41. Zimmermann P, Fimm B (2002). Testbatterie zur Aufmerksamkeitsprü fung,Version 1.7 (Test Battery of Attentional Performance). Vera Fimm/Psychologische Testsysteme: Herzogenrath.